Market revenue in 2023 | USD 679.2 million |
Market revenue in 2030 | USD 1,084.0 million |
Growth rate | 6.9% (CAGR from 2023 to 2030) |
Largest segment | Drug eluting stents (des) |
Fastest growing segment | Bioabsorbable Stents |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Drug Eluting Stents (DES), Bare Metal Stents (BMS), Bioabsorbable Stents |
Key market players worldwide | MicroPort Scientific Corp, Medtronic PLC, Terumo Corp, Abbott Laboratories, BIOTRONIK, LifeTech Scientific Corp, iVascular, Stryker Corp, Cook Medical, Boston Scientific Corp, Cardinal Health Inc, Stentys |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to peripheral vascular stents market will help companies and investors design strategic landscapes.
Drug eluting stents (des) was the largest segment with a revenue share of 60.23% in 2023. Horizon Databook has segmented the U.S. peripheral vascular stents market based on drug eluting stents (des), bare metal stents (bms), bioabsorbable stents covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. peripheral vascular stents market , including forecasts for subscribers. This country databook contains high-level insights into U.S. peripheral vascular stents market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account